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Postcardiac injury syndrome (PCIS) occurs following a pericardial or myocardial injury. On the other
hand, PCIS following cardiac catheter intervention is rare and can be difﬁcult to diagnose because of its
delayed onset. A 24-year-old man underwent radiofrequency ablation (RFA) for paroxysmal atrial
ﬁbrillation and suffered from general fatigue and left-sided pleural effusion three months after the
procedure. His symptoms and effusion were effectively treated within a month by administrating
nonsteroidal anti-inﬂammatory drugs. However, seven months later, he developed left-sided chest pain
and low-grade fever. Computed tomography showed a thickening of the parietal pleura and reccurence
of the pleural effusion. Pleural biopsy by video-assisted thoracoscopy demonstrated chronic pleuritis
with a non-necrotizing granulomatous reaction. Given the previous RFA, and in the absence of infection
or malignant disease, he was diagnosed with PCIS and treated with colchicine.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Postcardiac injury syndrome (PCIS) occurs following a pericar-
dial or myocardial injury [1]. The term PCIS includes Dressler's
syndrome and postpericardiotomy syndrome (PPS), which occur
following myocardial infarction or cardiac surgery. Typically, the
patient demonstrates fever elevation, irritability, pericardial fric-
tion rub, and pericardial effusion with or without pleural effusion
[2]. Recently, the development of PCIS after catheter ablation has
been reported in the literature [3,4], although it is considered to be
rare. We describe a case of PCIS following a radiofrequency ablation
(RFA) for paroxysmal atrial ﬁbrillation.2. Case report
A 24-year-old man consulted his primary care physician with
general fatigue and chest and back pain. Chest radiography
demonstrated a left-sided pleural effusion that was diagnosed as a
parapneumonic effusion, and he was treated with oral levoﬂoxacini).
Ltd. This is an open access article u500 mg per day. However, neither the pain nor effusion improved;
therefore, his primary care physician referred him to our
institution.
He had low-grade fever without any symptoms of either respi-
ratory disease or heart failure, but he had a history of interventional
RFA for paroxysmal atrial ﬁbrillation three month prior to the onset
of symptoms. On physical examination on admission, his temper-
ature was 37.4 C, heart rate 93 beats per min, blood pressure 110/
50 mmHg, respiratory rate 16 breaths per min, and pulse oximetry
97% oxygen saturation in room air. Radiography and computed
tomography (CT) of the chest demonstrated a left-sided interme-
diate pleural effusion and slightly thickened parietal pleura. A
transthoracic echocardiogram revealed 75% of left ventricular
ejection fraction without regional wall motion abnormalities and
normal level of pericardial effusion. The result of laboratory ex-
aminations were unremarkable except for a trivial increase of C-
reactive protein (CRP) level of 0.46 mg/dL. QuantiFERON-TB Gold
In-Tube assay was negative. Thoracentesis revealed a nonbloody
exudative effusion with lymphocytosis. There was no evidence of
infection or neoplasia in either the culture or the cytology results.
He was diagnosed with pleuritis and was prescribed oral lox-
oprofen in addition to original therapy. Both his symptoms and
pleural effusion gradually improved over the following month.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 2. Hematoxylin and eosin stain of a specimen from the left parietal pleura
revealed chronic pleuritis with a non-necrotizing granulomatous reaction.
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of intense chest pain. Chest radiography and CT showed the
reccurence of the left-sided pleural effusion accompanied by a
thickening of the parietal pleura (Fig. 1). He had a slightly elevated
CRP level at 1.72 mg/dL and a normal peripheral white blood cell
count of 7350 cells/mL.
Given his previous RFA for paroxysmal atrial ﬁbrillation three
months prior to the onset of his symptoms, we believed that the
series of events were highly indicative of PCIS. However, further
examination was required to exclude pleural tuberculosis and
malignancy. Pleural biopsy by video-assisted thoracoscopic surgery
(VATS) under general anesthesia was performed, and the histo-
logical specimens from the left parietal pleura demonstrated
chronic pleuritis with a non-necrotizing granulomatous reaction
(Fig. 2). Furthermore, cultures and polymerase chain reaction
analysis of the parietal pleurawere negative for mycobacterium. He
was clinically diagnosed with PCIS and was successfully treated
with colchicine 1 mg and Celecoxib 200 mg daily. The dose of
colchicine was reduced to 0.5 mg per day after three weeks and
discontinued after one month because of the development of
diarrhea.3. Discussion
PCIS is a condition that involves pleuropericarditis and follows
cardiac or pericardial injury from surgery, catheter procedures, or
trauma [3]. Although it is believed to be an autoimmune phe-
nomenon, the precise mechanism remains unknown [5,6]. Putative
etiological factors include traumatic events such as myocardial
infarction [1], cardiac surgery [7], a repair of pectus excavatum [8],
thymectomy [9] and cardiac catheter intervention [3,4,10]. On the
otherhand, only a few reports demonstrated PCIS following RFA.
The reported symptoms of PCIS in the manuscripts are low-
grade fever associated with pleural or pericardial inﬂammation.
Sometimes patients develop persistent symptomatic pleural effu-
sions [11e13]. In addition, these symptoms generally persist within
a few days to several months. The diagnosis of the PCIS is difﬁcult
because the onset may be delayed following the initial traumatic
event as presented case. In addition, lacking of characteristicFig. 1. Chest computed tomography showed a relapse of the left-sided pleural effusion
associated with a thickening of the parietal pleura seven months after the ﬁrst event.symptoms or laboratory ﬁndings in PCIS makes the diagnosis more
difﬁcult. Therefore, the diagnosis is generally made by exclusion.
Although the etiology of PCIS is poorly understood, it is thought
to be related to autoimmune disturbance [4,5]. RFA is sometimes
utilized for tumor destruction in cancer treatment, and it is pro-
posed that ablated tumor debris could be taken up by the immune
system to induce or enhance immune responses [14]. We speculate
that RFA of the atrium inﬂuences the surrounding pericardium or
other structures and triggers PCIS.
The treatment of PCIS is based on nonsteroidal anti-
inﬂammatory drugs and steroids. Colchicine has been effectively
used to prevent PCIS, but its efﬁcacy in the treatment of established
PCIS is unclear. In a recent report, colchicine administration for
pericarditis, including patients with PCIS, proved to be effective in
reducing the rate of incessant or recurrent pericarditis and in
prolonging the time to recurrence [15]. Aithough the exact mech-
anism of colchicine in PCIS remains unclear, it is still a key thera-
peutic option.
The histological ﬁndings of pleura in cases of persistent pleural
effusion after coronary artery bypass grafts have been well docu-
mented [16e18]. Although these cases were not diagnosed as PCIS,
their clinical features are consistent with PCIS. In these reports,
pleural biopsy by VATS revealed histological ﬁndings of chronic
pleuritis with inﬂammatory cell inﬁltration. In addition, some
formed non-necrotizing granulomatous changes, which are
consistent with the present case.
In conclusion, the diagnosis of PCIS in a case following cardiac
catheter intervention is difﬁcult because patients no longer suffer
from symptoms of the heart disease and general practitioner may
undertake the follow up role. Therefore, it would be a matter of
importance for clinicians to be aware of PCIS.References
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